A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors
AstraZeneca
AstraZeneca
Dutch Society of Physicians for Pulmonology and Tuberculosis
Neonc Technologies, Inc.
Azienda Ospedaliero-Universitaria di Parma
University of Oklahoma
Eli Lilly and Company
University of Colorado, Denver
Maia Biotechnology
Onchilles Pharma Inc
Ocellaris Pharma, Inc.
Maia Biotechnology
Mayo Clinic
Inhibrx Biosciences, Inc
TScan Therapeutics, Inc.
University of Pittsburgh
Mayo Clinic
Numab Therapeutics AG
University of Birmingham
Revolution Medicines, Inc.
Creative Biosciences (Guangzhou) Co., Ltd.
Intensity Therapeutics, Inc.
Sarcoma Oncology Research Center, LLC
Carisma Therapeutics Inc
Advaxis, Inc.
Advaxis, Inc.
Pfizer
Sinocelltech Ltd.
Umeå University
H. Lee Moffitt Cancer Center and Research Institute
Revolution Medicines, Inc.
Tianjin Medical University Cancer Institute and Hospital
Seagen Inc.
Fate Therapeutics
Wuhan University
H. Lee Moffitt Cancer Center and Research Institute
Rain Oncology Inc
Amgen
M.D. Anderson Cancer Center
Revolution Medicines, Inc.
MacroGenics
Takeda
Mayo Clinic
SpeciCare
Celgene
Lumos Pharma
Ottawa Hospital Research Institute
M.D. Anderson Cancer Center
Tianjin Medical University Cancer Institute and Hospital
M.D. Anderson Cancer Center
Hoffmann-La Roche